You can help researchers, and the medical community better understand Parkinson’s disease and other neurological conditions by participating in a clinical research study.
Find out more about CND’s active clinical studies below.
Syn-Q Study
Quantification of Phosphorylated Alpha-Synuclein (P-SYN) in Cutaneous Biopsies as a Prospective Biomarker in Parkinson’s Disease
A study involving 75 patients with Parkinson’s disease and 25 patients with REM sleep behavior disorder. Each participant will undergo a baseline evaluation and follow-up every six months over an 18-month period. The evaluations will include clinical assessments, neurologic exams, and skin biopsies from three locations. Data will be collected on disease progression and the amount of P-SYN in cutaneous nerve fibers.
If you’re interested in participating in this study, please complete this form and a member of our CND research team will contact you.
ClinicalTrials.gov ID NCT06621602
The Long COVID Cutaneous Signatures (LCCS) Study
A study involving 300 participants to compare Long COVID neurocutaneous biosignatures with those of other disorders affecting the sensory and autonomic nervous system. The evaluations will include clinical assessments, neurologic exams, patient-reported outcome surveys, and skin biopsies from three locations. Data will be collected on the amount of P-SYN in cutaneous nerve fibers.
Who we’re looking for:
- 100 participants with Long COVID
- 100 participants with who tested positive for COVID without persistent symptoms
- 50 participants with postural orthostatic tachycardia syndrome (POTS)
- 50 participants with diabetic neuropathy
If you’re interested in participating in this study, please complete this form and a member of our CND research team will contact you.
ClinicalTrials.gov ID NCT07005947
